Abigail (Lauterbach) Schmitz
Senior Associate
RA Capital Management
TechAtlas senior associate evaluating biotech opportunities and competitive landscapes.
Bio
Professional summary
Henry Stusnick is an Analyst on the Investment Team at RA Capital Management. He works with the investment team and portfolio companies to understand competitive landscapes, evaluate investment opportunities across therapeutic areas from discovery through commercialization, and advise on program and pipeline strategy. Kinaset Therapeutics lists him as a board director, and a 2026 financing announcement named him as joining Kinaset's board in connection with its Series B financing.
Notable companies
Selected portfolio companies the partner has backed
Kinaset TherapeuticsAmbros TherapeuticsSparrow Pharmaceuticals
Background
Career, education, and skills
Career history
- RA Capital ManagementAnalyst
- SVB LeerinkInvestment Banking Analyst
Education
- Dartmouth CollegeBA in Biology and Economics
Other partners at RA Capital Management
12 more profiles
Adam Prince, MD
Senior Associate, Strategic Initiatives
RA Capital Management
RA Capital TechAtlas senior associate with cardiology and medical training.
Alana MacDonald, Ph.D.
Senior Associate
RA Capital Management
Senior TechAtlas associate focused on biotech diligence, landscapes, and portfolio strategy.
Alejandro Sevilla
Associate
RA Capital Management
Planetary Health associate focused on climate-tech landscapes and investment evaluation.
Alex Miller
Senior Associate, Venture
RA Capital Management
Venture senior associate focused on biotech diligence and portfolio strategy.
Alex T. Zhang
Vice President, Structured Capital
RA Capital Management
Structured Capital VP focused on healthcare and life-sciences credit investments.
Alexander Martinez-Forte
Director, Quantitative Research & Strategy
RA Capital Management
RA Capital director leading quantitative analyses for investment decisions and portfolio management.
Allison Harrigan
Senior Director Corporate Development
RA Capital Management
Raven corporate development leader focused on biotech company creation.
Alyssa Larson
Director, Healthcare Specialist - Investor Relations
RA Capital Management
TechAtlas director supporting healthcare diligence and investor relations.
Ami Thakrar, PhD
Associate
RA Capital Management
TechAtlas associate focused on biotech diligence and program strategy.
Anish K. More
Vice President, Corporate Development
RA Capital Management
Raven corporate-development VP focused on investment evaluation and NewCo creation.
Anurag Kondapalli
Principal
RA Capital Management
Principal investing across public and private healthcare technology and services companies.